Source:http://linkedlifedata.com/resource/pubmed/id/15138613
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2004-5-12
|
pubmed:abstractText |
Cyclooxygenase (COX)-2 plays an important role in the development of various cancers due to its angiogenic function. We have demonstrated that the expression of COX-2 was up-regulated in human renal cell carcinoma (RCC), bladder tumor (BT) and prostate cancer (PC). In this study, we examined the effects of COX-2 inhibitors on cell proliferation in RCC, BT and PC-derived cell lines using MTT assay and Hoechst staining. COX-2 inhibitors did not induce a reduction of cell viability with the half-maximal concentration of growth inhibition of RCC, BT and PC cell lines. Furthermore, counting cells at days 1, 2 and 3, showed no inhibition of cell proliferation using COX-2 inhibitors. COX-2 inhibitors could not stop the growth of RCC, BT and PC cells. Typical characteristics of apoptosis, i.e. chromatin condensation, cellular shrinkage, small membrane-bound bodies (apoptotic bodies) and cytoplasmic condensation, did not occur. Although the expression of COX-2 was up-regulated in human RCC, BT and PC tissues, COX-2 inhibitors have only slight anti-proliferative effects against RCC, BT and PC cells through differentiation. Thus, using only down-regulation of arachidonic acid (AA) metabolizing enzyme, COX may be an unsuccessful approach in providing new anti-cancer therapies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase 2 Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/PTGS2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin-Endoperoxide Synthases
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1107-3756
|
pubmed:author |
pubmed-author:KawahitoYutakaY,
pubmed-author:KuratsukuriKatsuyukiK,
pubmed-author:MatsuyamaMasahideM,
pubmed-author:NakataniTatsuyaT,
pubmed-author:SanoHajimeH,
pubmed-author:SegawaYoshihiroY,
pubmed-author:ShinnkaToshiakiT,
pubmed-author:TakemotoYoshiakiY,
pubmed-author:TsuchidaKenjiK,
pubmed-author:YoshimuraRikioR
|
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
789-93
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15138613-Apoptosis,
pubmed-meshheading:15138613-Cell Division,
pubmed-meshheading:15138613-Cyclooxygenase 2,
pubmed-meshheading:15138613-Cyclooxygenase 2 Inhibitors,
pubmed-meshheading:15138613-Cyclooxygenase Inhibitors,
pubmed-meshheading:15138613-Humans,
pubmed-meshheading:15138613-Isoenzymes,
pubmed-meshheading:15138613-Membrane Proteins,
pubmed-meshheading:15138613-Prostaglandin-Endoperoxide Synthases,
pubmed-meshheading:15138613-Tumor Cells, Cultured,
pubmed-meshheading:15138613-Urologic Neoplasms
|
pubmed:year |
2004
|
pubmed:articleTitle |
The effects of cyclooxygenase-2 inhibitors on urological cancer cells.
|
pubmed:affiliation |
Department of Urology, Osaka City University Hospital, Abeno-ku, Osaka 545-8585, Japan. jasmin@med.osaka-cu.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|